Back to search

Aristotle University Of Thessaloniki (AUTH)

Συσχέτιση των πολυμορφισμών της λιποπρωτεϊνικής λιπάσης (LpL) και της απολιποπρωτεΐνης Ε (apoE) με τη λιπιδαιμική ταυτότητα παιδιών με οξεία λεμφοβλαστική λευχαιμία κατά τη διάρκεια της θεραπείας με ασπαραγινάση

Abstract

dc:description

Background:. Acute leukemias represent the most common malignant disease in childhood. Acute lymphoblastic leukemia (ALL) is the most common type of childhood leukemia, representing approximately 75% of all cases. L-Asparaginase (L-ASP) is a valuable agent in the treatment of pediatric ALL. However, its use has been associated with disturbances in the lipid profile. These can also be associated with polymorphisms of the Lipoprotein Lipase (LpL) and Apolipoprotein-E (apoE) genes. Aim:1.Study of the effect of asparaginase administration on the lipid profile of these patients2.Correlation of lipoprotein lipase (LpL) and apolipoprotein E (apoE) polymorphisms with lipid values during the chemotherapy protocol.3.Evaluation of the frequency of genotypic patterns and alleles of the studied polymorphisms in relation to the risk group (HR, IR) in children with ALLPatients-Methods: We studied the lipid profile of 30 children with ALL by measuring the following parameters: total cholesterol, triglycerides, high-density lipoprotein [HDL] cholesterol, low-density lipoprotein [LDL] cholesterol, Apolipoprotein-α1 [Apo-Α1], Apolipoprotein-B100 [Αpo-B100], Lipoprotein-α [Lp-α], glucose, SGOT, SGPT, TSH, FT4, amylase and lipase after the administration of L-ASP. We also investigated the association between the lipid profile, certain LpL and APOE-gene polymorphisms (rs268, rs328, rs1801177, and rs7412, rs429358, respectively). Respective measurements were performed on 30 pediatric ALL survivors as well as 30 healthy controls. Results: Among the rs429358, rs7412, rs 328, rs180177 and rs268 polymorphisms the only one that exhibited significant allelic and genotypic heterogeneity was rs429358 and was further studied. Significant differences were observed in the lipid profile of children with ALL at diagnosis compared to the two control groups (triglycerides, HDL-cholesterol, Apo-A1 and Apo-B100 levels). During Induction, total cholesterol, HDL-cholesterol and Apo-Α1 levels increased significantly at most timepoints. Levels of triglycerides, Αpo-B100 and Lp-α showed a downward trend. No change was observed during the re-induction. No statistically significant difference was found for any of the examined variables during treatment of High-Risk patients. It was also shown that the genotype (CC or CT or TT) was significantly associated with: 1) changes in the lipid profile at the end of consolidation (total cholesterol, LDL, apo-B100, lipoprotein a) and during re-induction (total cholesterol, apo-B100), and 2) with classification in the high risk-ALL subgroup (for CC genotype/C allele presence). Conclusion: This study is the first to evaluate alterations in the lipid profile in pediatric patients with ALL in Greece. It seems that lipid abnormalities during treatment in children with ALL could be associated with the ApoE genotype, which is also possibly related to risk stratification. The role of L-Asparaginase administration and other medications in these fluctuations needs to be further elucidated. Larger studies with more patients from various ethnic backgrounds are needed to confirm our results.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Ioannidou, Maria
  • Ιωαννίδου, Μαρία

Subjects

dc:subject × 13

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/54973

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Ioannidou, Maria; Ιωαννίδου, Μαρία. Συσχέτιση των πολυμορφισμών της λιποπρωτεϊνικής λιπάσης (LpL) και της απολιποπρωτεΐνης Ε (apoE) με τη λιπιδαιμική ταυτότητα παιδιών με οξεία λεμφοβλαστική λευχαιμία κατά τη διάρκεια της θεραπείας με ασπαραγινάση. Aristotle University Of Thessaloniki (AUTH), 2023. http://hdl.handle.net/10442/hedi/54973